A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization

Molecular Therapy : the Journal of the American Society of Gene Therapy
Esther DrentTuna Mutis

Abstract

Chimeric antigen receptors (CARs) can effectively redirect cytotoxic T cells toward highly expressed surface antigens on tumor cells. The low expression of several tumor-associated antigens (TAAs) on normal tissues, however, hinders their safe targeting by CAR T cells due to on-target/off-tumor effects. Using the multiple myeloma (MM)-associated CD38 antigen as a model system, here, we present a rational approach for effective and tumor-selective targeting of such TAAs. Using "light-chain exchange" technology, we combined the heavy chains of two high-affinity CD38 antibodies with 176 germline light chains and generated ∼124 new antibodies with 10- to >1,000-fold lower affinities to CD38. After categorizing them into three distinct affinity classes, we incorporated the single-chain variable fragments of eight antibodies from each class into new CARs. T cells carrying these CD38-CARs were extensively evaluated for their on-tumor/off-tumor cytotoxicity as well as CD38-dependent proliferation and cytokine production. We identified CD38-CAR T cells of ∼1,000- fold reduced affinity, which optimally proliferated, produced Th1-like cytokines, and effectively lysed CD382+ MM cells, but spared CD38+ healthy hematopoietic cells in vitro a...Continue Reading

Associated Clinical Trials

Citations

Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shivani Srivastava, Stanley R Riddell
Oct 6, 2017·Expert Opinion on Biological Therapy·Elisa Landoni, Barbara Savoldo
Sep 21, 2017·Blood·Lekha Mikkilineni, James N Kochenderfer
Nov 6, 2018·Expert Opinion on Biological Therapy·Francesca BonelloFrancesca Gay
Oct 12, 2018·Panminerva Medica·Mohammed A AljamaDavid Dingli
Jan 12, 2019·American Journal of Hematology·Mark B Leick, Marcela V Maus
Dec 19, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Roslin Y DoctaAndrew B Gerry
Feb 14, 2019·The Korean Journal of Internal Medicine·Manh-Cuong VoJe-Jung Lee
Sep 26, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Emiliano RoselliDaniel Abate-Daga
Jan 29, 2020·American Journal of Clinical Oncology·Vishal JindalIshmael Jaiyesimi
Oct 18, 2019·PloS One·Kristina PetrovicSteven P Lee
Jun 13, 2019·Journal of Hematology & Oncology·Hao WangXingxing Zang
Mar 23, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Shebli AtrashAl-Ola Abdallah
Jun 17, 2020·JCI Insight·Mauro CastellarinCarl H June
Aug 22, 2020·Expert Opinion on Investigational Drugs·Ying JiaoKongming Wu
May 28, 2019·Expert Review of Hematology·Nicola GiulianiFabio Malavasi
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Adam D Cohen
Dec 14, 2018·Frontiers in Immunology·Fabio MorandiFabio Malavasi
Jan 4, 2020·Journal of Zhejiang University. Science. B·He HuangYong-Xian Hu
Jun 26, 2020·Frontiers in Immunology·Estefanía García-GuerreroJose Antonio Pérez-Simón
Jul 30, 2020·Cancers·Andriy ZhylkoAgnieszka Graczyk-Jarzynka
Jul 5, 2019·BMC Biotechnology·Alexandre JuilleratPhilippe Duchateau
Jan 8, 2020·Nature Biotechnology·Matthew MacKayChristopher E Mason
Jun 24, 2020·Leukemia·Nico GagelmannNicolaus Kröger
Sep 23, 2020·BMJ : British Medical Journal·Urvi A Shah, Sham Mailankody
Aug 28, 2020·Frontiers in Oncology·Luis Gerardo Rodríguez-LobatoSophia Danhof
Jun 9, 2018·Gene Therapy·Mauro CastellarinAvery D Posey
Apr 24, 2019·Nature Biomedical Engineering·Louai LabaniehCrystal L Mackall
Jun 28, 2019·Therapeutic Advances in Hematology·Dawn SwanMichael O'Dwyer
Aug 6, 2019·Frontiers in Immunology·Marijke TimmersSébastien Anguille
Dec 7, 2019·Hematology·Surbhi Sidana, Nina Shah
Jan 2, 2020·International Journal of Molecular Sciences·Hannah E Hughes-ParryMisty R Jenkins
Aug 13, 2020·Cancers·Ada Hang-Heng WongWee-Joo Chng
Aug 10, 2020·Bone Marrow Transplantation·Binod DhakalMehdi Hamadani
Aug 28, 2020·Frontiers in Oncology·Jort J van der SchansTuna Mutis
Sep 12, 2018·Journal of the National Cancer Institute·Hua JiangZonghai Li
Nov 23, 2019·Journal of Hematology & Oncology·Chao WuLijuan Chen
Sep 23, 2019·Cancer Immunology, Immunotherapy : CII·Elvira D'IppolitoDirk H Busch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.